Bhavik Shah, PharmD

Contact Dr. Shah

130 South 9th Street
Suite 1540
Philadelphia, PA 19107

(215) 503-3793
(215) 503-9052 fax

Education
PharmD, School of Pharmacy, Rutgers University, The State University of New Jersey

Residency
PGY-1, Thomas Jefferson University Hospital, Pharmacy Practice

PGY-2, Thomas Jefferson University Hospital, Infectious Diseases

University Appointment
Assistant Professor, August 2010

Certification
Board Certified Pharmacotherapy Specialist (BCPS)

Professional Organizations
American College of Clinical Pharmacy (ACCP)
Mid-Atlantic College of Clinical Pharmacy (MACCP)
American Society of Health-Systems Pharmacists (ASHP)

Research/Clinical Interests
Internal Medicine, Infectious Diseases

Publications

Most recent Peer-reviewed Publications

1. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders
2. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: A social validity study
3. Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures
4. Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism
5. A prospective open trial of guanfacine in children with pervasive developmental disorders
6. Children's yale-brown obsessive compulsive scale modified for pervasive developmental disorders
7. Acute and long-term safety and tolerability of risperidone in children with autism
8. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity
9. Risperidone for the core symptom domains of autism: Results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology
10. Parent-defined target symptoms respond to risperidone in RUPP Autism study: Customer approach to clinical trials
11. Psychiatric disorders in Prader-Willi syndrome: Epidemiology and management
12. Risperidone was safe and effective for short term treatment of children with autism and serious behavioural disturbances
13. Psychiatric illness in a clinical sample of children with prenatal alcohol exposure
14. Maladaptive behaviour in children and adolescents with Down's syndrome
15. Risperidone in children with autism and serious behavioral problems
16. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder
17. Mental retardation: A review of the past 10 years. Part I
18. Eating themselves to death: Have 'personal rights' gone too far in treating people with prader-willi syndrome?
19. Clozapine-chlorpromazine allergic cross-reactivity in a psychotic patient with asymptomatic AIDS [2]

View All Publications